Shared on07 Aug 25Fair value Decreased 22%
Clover Health Investments' consensus price target has declined, as the company's lower future P/E suggests moderated growth expectations despite an improvement in net profit margin, resulting in a revised fair value of $4.31. What's in the News Launched a community-based pharmacy pilot program in New Jersey with IPC Digital Health, aiming to improve medication management for seniors through local pharmacies and AI-powered tools.